Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 357

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 357
---
 possible diversion of management attention for an extended period of time during the pendency of the Mergers and, following Closing, the integration of the two companies; |

| • |     | the effect that the length of time from announcement of the Mergers until consummation of the Mergers could have on the market price of TuHURA Common Stock and the relationship with TuHURA’s employees, stockholders, customers, suppliers, regulators and others who do business with TuHURA; |

| • |     | the Kineta stockholders may not approve the Merger Agreement Proposal; |

| • |     | the substantial costs to be incurred in connection with the Mergers, including those incurred regardless of whether the Mergers are consummated; |

| • |     | that there are limited circumstances in which the TuHURA Board of Directors may terminate the Merger Agreement; |

216

| • |     | that TuHURA would be required to pay to Kineta a termination fee of $1,000,000 in the event the Merger Agreement were to be terminated because of TuHURA’s failure to close the Concurrent Investment and obtain not less than $35,000,000 therefrom before the outside date; |

| • |     | the potential impact on the market price of TuHURA Common Stock as a result of the issuance of the Merger Consideration to Kineta stockholders; |

| • |     | That certain executive officers and directors of TuHURA may have interests in the Mergers that may be different from, or in addition to, the interests of TuHURA stockholders generally; and |

| • |     | risks of the type and nature described under entitled “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements.” |

The foregoing description of TuHURA’s consideration of the factors supporting the Mergers is forward-looking in nature. This information should be read in light of the factors discussed under “Cautionary Statement Regarding Forward-Looking Statements.” Recommendation of the Kineta Board of Directors; Kineta’s Reasons for the Transactions On December 11, 2024, the Kineta Board of Directors unanimously:

| • |     | determined that the Merger Agreement and the Mergers are fair to, and in the best interests of, Kineta and its stockholders; |

| • |     | approved and declared advisable the Merger Agreement and the Mergers; |

| • |     | directed the